Search by Drug Name or NDC
NDC 00113-0374-62 good sense migraine formula 250; 250; 65 mg/1; mg/1; mg/1 Details
good sense migraine formula 250; 250; 65 mg/1; mg/1; mg/1
good sense migraine formula is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by L. Perrigo Company. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 00113-0374 |
|---|---|
| Product ID | 0113-0374_caed078a-263c-49b9-8653-3c6aab20fefe |
| Associated GPIs | 64990003200350 |
| GCN Sequence Number | 040186 |
| GCN Sequence Number Description | aspirin/acetaminophen/caffeine TABLET 250-250-65 ORAL |
| HIC3 | H3D |
| HIC3 Description | ANALGESIC/ANTIPYRETICS, SALICYLATES |
| GCN | 10414 |
| HICL Sequence Number | 001807 |
| HICL Sequence Number Description | ASPIRIN/ACETAMINOPHEN/CAFFEINE |
| Brand/Generic | Generic |
| Proprietary Name | good sense migraine formula |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Acetaminophen, Aspirin, Caffeine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | L. Perrigo Company |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075794 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00113-0374-62 (00113037462)
| NDC Package Code | 0113-0374-62 |
|---|---|
| Billing NDC | 00113037462 |
| Package | 1 BOTTLE in 1 CARTON (0113-0374-62) / 24 TABLET, FILM COATED in 1 BOTTLE |
| Marketing Start Date | 2002-04-17 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.06567 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | GS MIGRAINE FORMULA CAPLET |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis